ATE144711T1 - Verfahren und zubereitungen für die behandlung von verletzungen - Google Patents

Verfahren und zubereitungen für die behandlung von verletzungen

Info

Publication number
ATE144711T1
ATE144711T1 AT91909076T AT91909076T ATE144711T1 AT E144711 T1 ATE144711 T1 AT E144711T1 AT 91909076 T AT91909076 T AT 91909076T AT 91909076 T AT91909076 T AT 91909076T AT E144711 T1 ATE144711 T1 AT E144711T1
Authority
AT
Austria
Prior art keywords
preparations
methods
treating injuries
chemotherapy
synergistic
Prior art date
Application number
AT91909076T
Other languages
English (en)
Inventor
David V Goeddel
Charles H Schmelzer
Grace H W Wong
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27055814&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE144711(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE144711T1 publication Critical patent/ATE144711T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91909076T 1990-04-10 1991-04-09 Verfahren und zubereitungen für die behandlung von verletzungen ATE144711T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50734190A 1990-04-10 1990-04-10
US60284990A 1990-10-26 1990-10-26

Publications (1)

Publication Number Publication Date
ATE144711T1 true ATE144711T1 (de) 1996-11-15

Family

ID=27055814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909076T ATE144711T1 (de) 1990-04-10 1991-04-09 Verfahren und zubereitungen für die behandlung von verletzungen

Country Status (11)

Country Link
US (2) US5843422A (de)
EP (2) EP0731109A1 (de)
JP (1) JP3266248B2 (de)
AT (1) ATE144711T1 (de)
CA (1) CA2078544C (de)
DE (1) DE69122960T3 (de)
DK (1) DK0527852T3 (de)
ES (1) ES2095938T3 (de)
GR (1) GR3022097T3 (de)
IL (1) IL97779A (de)
WO (1) WO1991015227A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
CA2092718C (en) * 1990-10-25 2007-08-07 Grace H. W. Wong Use of protective agents against reactive oxygen species
US5460810A (en) 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
US7602940B2 (en) 1998-04-16 2009-10-13 Digimarc Corporation Steganographic data hiding using a device clock
FR2786104B1 (fr) * 1998-11-25 2002-12-27 Centre Nat Rech Scient Inhibiteurs de l'activation de nf-kb, et leurs utilisations pharmaceutiques
US8288366B2 (en) 2006-06-20 2012-10-16 Chochinov Ronald H Formulation for hair growth
EA021042B1 (ru) * 2009-10-08 2015-03-31 Юнайтед Технолоджиес Ют Аг Способ снижения выпадения волос при помощи косметических композиций, содержащих интерлейкин-1 альфа
JP5913479B2 (ja) * 2014-08-11 2016-04-27 リゼロン、インク． ヒト成長ホルモンを有効成分として含む発毛の促進用の組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321832A (en) * 1980-03-07 1982-03-30 Rockwell International Corporation High accuracy measuring apparatus
NZ212207A (en) * 1984-05-31 1991-07-26 Genentech Inc Recombinant lymphotoxin
GR851626B (de) * 1984-07-05 1985-11-26 Genentech Inc
JPH01501862A (ja) * 1986-03-14 1989-06-29 シェリング・コ−ポレ−ション インタ−フェロン及び放射線療法による癌の治療
DE3613167A1 (de) † 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
IL80005A (en) * 1986-09-10 1992-11-15 Yeda Res & Dev Compositions for modulating the effect of tnf and il-1
US4985241A (en) * 1986-11-21 1991-01-15 Cetus Corporation Therapeutic combination of free-radical scavenger and tumor necrosis factor
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
WO1989010158A1 (en) * 1988-04-27 1989-11-02 Immunomedics, Inc. Improved radiotherapy
WO1990002183A1 (en) * 1988-08-18 1990-03-08 Genetics Institute, Inc. Production of a novel lymphokine exhibiting differentiation inhibitory activity
JP3055802B2 (ja) * 1989-03-07 2000-06-26 アムラド・コーポレイション・リミテッド 骨に対する白血病抑制因子の代謝効果
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response

Also Published As

Publication number Publication date
DE69122960D1 (de) 1996-12-05
US5843422A (en) 1998-12-01
ES2095938T3 (es) 1997-03-01
EP0527852B2 (de) 2001-02-21
AU7856591A (en) 1991-10-30
CA2078544A1 (en) 1991-10-11
DK0527852T3 (de) 1997-02-17
EP0527852B1 (de) 1996-10-30
CA2078544C (en) 2008-02-26
AU638839B2 (en) 1993-07-08
DE69122960T3 (de) 2002-05-29
DE69122960T2 (de) 1997-04-03
EP0527852A1 (de) 1993-02-24
GR3022097T3 (en) 1997-03-31
US5725851A (en) 1998-03-10
JP3266248B2 (ja) 2002-03-18
WO1991015227A1 (en) 1991-10-17
IL97779A0 (en) 1992-06-21
JPH05506663A (ja) 1993-09-30
IL97779A (en) 2000-01-31
EP0731109A1 (de) 1996-09-11

Similar Documents

Publication Publication Date Title
TW229156B (de)
DE69523350D1 (de) Behandlung von hyperproliferativen Gefässerkrankungen
NO304884B1 (no) 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav
UY23635A1 (es) Procedimiento para la preparacion de conjugados del peg interferon
DE69304955D1 (de) Behandlung von neurodegenerativen Erkrankungen
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
OA06421A (fr) Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
ES2154686T3 (es) Compuestos de piridazino-quinolina.
ATE144711T1 (de) Verfahren und zubereitungen für die behandlung von verletzungen
ATE71843T1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
FI831230A0 (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
ATE181329T1 (de) Substituierte dibenzooxazepin-verbindungen, pharmazeutische zusammensetzungen und verfahren zur verwendung
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
FR2714059B1 (fr) Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
ATE168557T1 (de) Topische zubereitungen enthaltend aliphatische amine zur behandlung von hautkrankheiten
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE125704T1 (de) Behandlung neurodegenerativer erkrankungen.
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
DE3682330D1 (de) Monoalkylester-sulfate von glutathion und verfahren zu deren herstellung.
NO893249L (no) Cykliske svovelinneholdende forbindelser.
DK601888D0 (da) Anvendelse af 2-pyrimidinyl-1-piperazinderivater
FR2682950B1 (fr) Procede d'elimination de la diethanolamine presente dans la triethanolamine et procede de preparation de triethanolamine purifiee.
ATE80396T1 (de) Alpha-hydroxy-azolylethyloxirane und diese enthaltende fungizide.
ATE78407T1 (de) Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten.
ATE129706T1 (de) Verfahren zur direkten und regioselektiven funktionalisierung in stelle 2 von phenothiazin.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties